In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Sagimet Biosciences Inc’s stock clocked out at $9.83, up 17.58% from its previous closing price of $8.36. In other words, the price has increased by $17.58% from its previous closing price. On the day, 2.83 million shares were traded. SGMT stock price reached its highest trading level at $10.425 during the session, while it also had its lowest trading level at $8.37.
Ratios:
To gain a deeper understanding of SGMT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.26 and its Current Ratio is at 20.26. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on December 06, 2024, initiated with a Outperform rating and assigned the stock a target price of $30.
On November 12, 2024, UBS started tracking the stock assigning a Buy rating and target price of $12.
Goldman Downgraded its Buy to Neutral on June 28, 2024, whereas the target price for the stock was revised from $23 to $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 23 ’24 when Kemble George sold 23,625 shares for $3.17 per share. The transaction valued at 74,830 led to the insider holds 118,693 shares of the business.
Martins Eduardo Bruno sold 8,357 shares of SGMT for $25,910 on Jul 19 ’24. The Chief Medical Officer now owns 81,213 shares after completing the transaction at $3.10 per share. On Jul 19 ’24, another insider, Rozek Elizabeth, who serves as the General Counsel and CCO of the company, sold 10,914 shares for $3.10 each. As a result, the insider received 33,830 and left with 160,506 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 316479808 and an Enterprise Value of 171950240.
Stock Price History:
The Beta on a monthly basis for SGMT is 2.52, which has changed by 1.4949238 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, SGMT has reached a high of $9.60, while it has fallen to a 52-week low of $1.73. The 50-Day Moving Average of the stock is 144.24%, while the 200-Day Moving Average is calculated to be 130.57%.
Shares Statistics:
It appears that SGMT traded 1.39M shares on average per day over the past three months and 3266000 shares per day over the past ten days. A total of 30.67M shares are outstanding, with a floating share count of 23.62M. Insiders hold about 26.63% of the company’s shares, while institutions hold 36.23% stake in the company. Shares short for SGMT as of 1748563200 were 3661543 with a Short Ratio of 2.63, compared to 1745971200 on 3885103. Therefore, it implies a Short% of Shares Outstanding of 3661543 and a Short% of Float of 12.889999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
